Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Martin Michaelis

Showing results (101-110 of 214) with videos related to

Pageof 22
Sort By:
International Journal of Molecular Sciences|October 14, 2023
Loss of Key EMT-Regulating miRNAs Highlight the Role of ZEB1 in EGFR Tyrosine Kinase Inhibitor-Resistant NSCLCLinus Gohlke, Ahmad Alahdab, Angela Oberhofer, et al.
International Journal of Molecular Sciences|March 10, 2018
Key Players of Cisplatin Resistance: Towards a Systems Pharmacology ApproachNavin Sarin, Florian Engel, Florian Rothweiler, et al.
Molecules (Basel, Switzerland)|May 28, 2025
Colchicine Binding Site Tubulin Inhibitors Impair Vincristine-Resistant Neuroblastoma Cell FunctionCinthia N Reed, Kaylee B Garrison, Joshua Thammathong, et al.
Cellular and Molecular Life Sciences : CMLS|August 31, 2010
The multi-targeted kinase inhibitor sorafenib inhibits human cytomegalovirus replicationMartin Michaelis, Christina Paulus, Nadine Löschmann, et al.
BMC Research Notes|October 11, 2014
Association between acquired resistance to PLX4032 (vemurafenib) and ATP-binding cassette transporter expressionMartin Michaelis, Florian Rothweiler, Thomas Nerreter, et al.
Medical Microbiology and Immunology|December 17, 2009
Tumor cells infected with oncolytic influenza A virus prime natural killer cells for lysis of resistant tumor cellsHenry Ogbomo, Martin Michaelis, Janina Geiler, et al.
Chemmedchem|December 13, 2019
Thiourea and Guanidine Compounds and Their Iridium Complexes in Drug-Resistant Cancer Cell Lines: Structure-Activity Relationships and Direct Luminescent ImagingSamuel J Thomas, Barbora Balónová, Jindrich Cinatl, et al.
The Journal of Infection|August 2, 2022
Synergism of interferon-beta with antiviral drugs against SARS-CoV-2 variantsDenisa Bojkova, Richard Stack, Tamara Rothenburger, et al.
Journal of Medicinal Chemistry|February 18, 2005
Antiviral activity of glycyrrhizic acid derivatives against SARS-coronavirusGerold Hoever, Lidia Baltina, Martin Michaelis, et al.
Plos One|May 8, 2012
Oncolytic effects of a novel influenza A virus expressing interleukin-15 from the NS reading frameMarijke van Rikxoort, Martin Michaelis, Markus Wolschek, et al.
Pageof 22

Showing results (101-110 of 214) with videos related to

Sort By:
Pageof 22
International Journal of Molecular Sciences|October 14, 2023
Loss of Key EMT-Regulating miRNAs Highlight the Role of ZEB1 in EGFR Tyrosine Kinase Inhibitor-Resistant NSCLCLinus Gohlke, Ahmad Alahdab, Angela Oberhofer, et al.
International Journal of Molecular Sciences|March 10, 2018
Key Players of Cisplatin Resistance: Towards a Systems Pharmacology ApproachNavin Sarin, Florian Engel, Florian Rothweiler, et al.
Molecules (Basel, Switzerland)|May 28, 2025
Colchicine Binding Site Tubulin Inhibitors Impair Vincristine-Resistant Neuroblastoma Cell FunctionCinthia N Reed, Kaylee B Garrison, Joshua Thammathong, et al.
Cellular and Molecular Life Sciences : CMLS|August 31, 2010
The multi-targeted kinase inhibitor sorafenib inhibits human cytomegalovirus replicationMartin Michaelis, Christina Paulus, Nadine Löschmann, et al.
BMC Research Notes|October 11, 2014
Association between acquired resistance to PLX4032 (vemurafenib) and ATP-binding cassette transporter expressionMartin Michaelis, Florian Rothweiler, Thomas Nerreter, et al.
Medical Microbiology and Immunology|December 17, 2009
Tumor cells infected with oncolytic influenza A virus prime natural killer cells for lysis of resistant tumor cellsHenry Ogbomo, Martin Michaelis, Janina Geiler, et al.
Chemmedchem|December 13, 2019
Thiourea and Guanidine Compounds and Their Iridium Complexes in Drug-Resistant Cancer Cell Lines: Structure-Activity Relationships and Direct Luminescent ImagingSamuel J Thomas, Barbora Balónová, Jindrich Cinatl, et al.
The Journal of Infection|August 2, 2022
Synergism of interferon-beta with antiviral drugs against SARS-CoV-2 variantsDenisa Bojkova, Richard Stack, Tamara Rothenburger, et al.
Journal of Medicinal Chemistry|February 18, 2005
Antiviral activity of glycyrrhizic acid derivatives against SARS-coronavirusGerold Hoever, Lidia Baltina, Martin Michaelis, et al.
Plos One|May 8, 2012
Oncolytic effects of a novel influenza A virus expressing interleukin-15 from the NS reading frameMarijke van Rikxoort, Martin Michaelis, Markus Wolschek, et al.
Pageof 22